Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type & Application The global positron emission tomography market will witness a robust CAGR of 4.03%, valued at $1057.15 million in 2021, expected to appreciate and reach $1508.56 million by 2030, confirms Strategic Market Research. Currently, the North American region has the most significant global industry size, valued at USD 360 million. A PET scan is an imaging examination technique that can assist in revealing the metabolic or biochemical activity of a patient’s tissues and organs. A radioactive substance (tracer) like fluoro-deoxy glucose is used in the PET scan to show normal and abnormal metabolic activity. A PET scan can help diagnose various illnesses, including cancer, heart problems, and brain issues. In a PET scan, a patient lies down on a small table that slides into a doughnut-shaped hole. The scanner then produces images of metabolic activity in the tissues and organs. According to Mayoclinic, the time taken for a PET-CT scan to complete is 30 minutes, while it takes 45 minutes for a PET-MRI scan. Market Drivers - Increasing Cases of Cancer, Expanded Coverage of PET Imaging, and Higher Success Rate The growing number of cancer patients worldwide is one of the key reasons for increasing the positron emission tomography market share. According to the World Health Organization, cancer has caused nearly 10 million deaths in 2020. The PET imaging devices market is growing due to its wide range of applications. PET imaging devices detect brain disorders, breast, cervical, colorectal, oesophageal, head and neck problems, lung problems, lymphatic system, pancreatic, prostate, skin, thyroid cancer, heart disease, cerebrovascular diseases, epilepsy, Huntington’s disease, and Parkinson’s disease. According to the Centre for Neurological Treatment and Research, one in 10,000 people in the United States has Huntington’s Disease. In addition, PET can also be used in cancer treatment and small animal imaging. The high success rate of PET causes more patients to opt for this technology, resulting in its market growth. According to a study, positron emission tomography is 97% to 100% successful in detecting recurrent tumours. Market Restraints - Continuous Reimbursement Cutbacks, Short Half-Life of Radiopharmaceuticals, and Costs of PET The continuous cutback of reimbursement is expected to slow down the market growth. Globally, decreasing payer reimbursement for PET and SPECT treatments has declined the outpatient volumes, impacting patient access to high-quality, cost-effective imaging and diagnostic services and doctors to look for other methods, such as PET-CT. According to the SNMMI (Society of Nuclear Medicine and Molecular Imaging), in 2021, CMS (Centres for Medicare and Medicaid Services) proposed cutting the beta-amyloid PET conversion factor from USD 34.89 in 2021 to USD 33.58 in 2022. The radiopharmaceuticals’ short half-life is also expected to hinder the market growth. Fluoro-deoxy glucose (FDG), which uses fluorine-18 as the tracer, is the most often used radiotracer in PET imaging. According to the American Chemical Society, fluorine-18 has a half-life of 20 minutes. As a result, it has limited diagnostic imaging capabilities. The high costs of PET can also hinder the market growth. The cost of the radiopharmaceutical was estimated to be around $700 per dose with a modest level of production (about 12 doses per day). Also, the average cost of PET scans (technical scan and professional charges) ranged from around $900 to $1400. Market Opportunities - Increased adoption of newer PET Techniques and Products, Formation of Guidelines in Radiopharmaceuticals, and Application in Newer Segments The increased adoption of newer PET techniques will help shift the positron emission tomography market trends. In addition, more unique positron emission tomography imaging techniques (like dual-modality imaging), brain positron emission tomography, CPET scan, positron emission tomography drugs, and heart positron emission tomography can help increase the growth rate of the Positron Emission Tomography Scanners market, thus catering to ample opportunities in the future. The development of radiopharmaceutical manufacturing standards is projected to help in market expansion. The International Atomic Energy Agency, for example, authorised a project in February 2020 to provide help and expertise in the manufacturing of cyclotron-based gallium-68 radioisotopes and associated radiopharmaceuticals. Market Analysis Of Different Segments Covered in the Report Based on Application Oncology Cardiology Neurology Others Based on Detector Type Bismuth Germanium Oxide (BGO) Lutetium Oxyorthosilicate (LSO) Gadolinium Oxyorthosilicate (GSO) Lutetium Fine Silicate (LFS) Lutetium Yttrium Orthosilicate (LYSO) Based on End-User Hospitals Diagnostic Centres PET Centres Research Institutes Regional Coverage Analysis North America United States of America Canada Rest of North America Europe United Kingdom Germany France Italy Spain Russia Netherlands Switzerland Turkey Poland Rest of Europe Asia-Pacific China Japan India Thailand South Korea Indonesia Taiwan Hong Kong Philippines Malaysia Rest of Asia-Pacific Latin America Brazil Mexico Argentina Colombia Chile Rest of Latin America The Middle East and Africa Saudi Arabia United Arab Emirates Iran Qatar Rest of the Middle East and Africa Segments Analysis & Insights By application, the Oncology segment accounted for more than 80% of the market share. The World Health Organization states that cancer is responsible for around one out of six deaths globally. Thus, due to the increasing demand for early cancer detection and treatment, the use of PET scanners has surged, resulting in market growth. The Lutetium Oxyorthosilicate (LSO) detector type segment had the largest market share, accounting for 36.0% of the worldwide Positron Emission Tomography (PET) scanners market. LSO crystals offer excellent light output and density, a short decay period, and excellent energy resolution, making them ideal for PET. The Institute of Electrical & Electronics Engineers, asserted that LSO has a light decay period of 40 ns. As a result, the widespread usage of LSO has resulted in significant market growth for PET devices. The Hospital category is the largest market segment based on end-user, valued at US$ 322.7 million. Due to the rising need for early cancer detection and treatment and the availability of skilled medical professionals in PET, the use of PET scanners has increased, resulting in the market growth. According to the Lawrence Berkeley Laboratory, around 2500 PET scanners in hospitals across the United States of America perform around 2 million scans per year. The North American region held the maximum market share by region, accounting for 42.2% of the worldwide Positron Emission Tomography (PET) scanners market. North America dominates the positron emission tomography industry because of the region’s high demand for precise diagnosis and technological advances in PET technology. According to the OECD, 6 PET scans were performed per 1000 population in 2018, which is expected to increase twinfold. Thus, the growing demand for PET scans led to the market’s growth in this segment. However, the Asia-Pacific region is expected to be the fastest-growing positron emission tomography market and is expected to reach around US$88.9 million by 2027, led by nations such as Australia, China, India, and South Korea. Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 1057.15 million Revenue forecast in 2030 USD 1508.56 million Growth rate CAGR of approximately 4.03% Base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By application, by end-user, by detector type, and by region. By Application Oncology, Cardiology, Neurology, Others By End-User Hospitals, Diagnostic Centres, PET Centres, Research Institutes By Detector Type Bismuth Germanium Oxide (BGO), Lutetium Oxyorthosilicate (LSO), Gadolinium Oxyorthosilicate (GSO), Lutetium Fine Silicate (LFS), Lutetium Yttrium Orthosilicate (LYSO) By Region Asia Pacific, North America, Europe, Latin America, the Middle East and Africa Country Scope United States of America, United Kingdom, Canada, Germany, France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Poland, China, Japan, India, Thailand, South Korea, Indonesia, Taiwan, Hong Kong, Philippines, Malaysia, Brazil, Mexico, Argentina, Colombia, Chile, etc. Company Usability Profiles Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens Healthineers AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc., MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi, Ltd., Cerveau Technologies, Inc. Global Positron Emission Tomography Market Competitive Landscape Analysis The industry has become more consolidated. Firms are implementing strategic operations such as mergers & acquisitions, new product launches, and partnerships to help them strengthen their market positions. Some of the major organisations in the market are: Agfa Healthcare GE Healthcare Neusoft Medical Systems Oncovision Koninklijke Philips N.V. Positron Corporation Siemens Healthineers AG Segami Corporation Spectrum Dynamics Ltd. CMR Naviscan MedX Holdings Inc. Modus Medical Devices Inc. Radiology Oncology Systems, Inc. Yangzhou Kindsway Biotech Co. Ltd. Toshiba Corporation Hitachi, Ltd. Cerveau Technologies, Inc. Recent Developments In January 2022, GE Healthcare received an additional FDA 510 (k) clearance for its SIGNA PET/MRI technology that could help more clinicians achieve enhanced scan efficiency. It will allow them to offer more effective treatment paths for their patients, particularly in the cardiology, oncology, and neurology departments. In January 2022, Positron Corporation announced its strategic collaboration with Neusoft Medical Systems to manufacture, distribute, and improve R&D improvements of Positron’s new PET-CT device. Positron Corporation believes that the collaboration will allow it to further develop its PET-CT technology while expanding into the oncology segment. In March 2021, Siemens Healthineers announced FDA Clearance on its Biograph Vision Quadra PET-CT Scanner, designed for translational and clinical use to apply scientific research to create therapies and procedures that improve health outcomes. Siemens believes that introducing the device helps clinicians better understand the disease under treatment by simultaneously imaging all vital organs under one field of view. In March 2020, Cerveau Technologies, Inc. announced its licensing agreement with Alector Inc. to use its investigational imaging agent in PET scans to assess the progression and status of neurofibrillary tangles (NFT) in the brain. Cerveau believes the partnership with Alector is an important stepping stone in its strategy to develop a global network of key collaborators and production sites to enable wide access to clinical trial support and scientific research. Various Leading Positron Emission Tomography Devices that Key Leaders Develop Name of the Product Function Key Players Discovery MI Molecular Imaging to assist in diagnosing and staging diseases early and guiding treatment strategies GE Healthcare Biograph mCT Detection of small lesions without compromising scheduling Siemens AG Solo II High-resolution Breast PET Scanner Precise detection of invasive and non-invasive diseases in the breasts Naviscan Attrius PET Camera Cardiac PET Imaging Positron Corporation Vereos Digital PET-CT Reliable detection of lesions Koninklijke Philips N.V. Frequently Asked Question About This Report Why is positron emission tomography important? A PET scan can help diagnose many illnesses, including cancer and heart and brain diseases. What is the positron emission Tomography technique? During a positron emission tomography (PET) scan, a patient lies down on a small table that slides into a doughnut-shaped hole. In around 30 minutes, the scanner produces images of metabolic activity in the patient’s tissues and organs. What is the positron emission tomography market growth? The global positron emission tomography market is expected to grow at a compound annual growth rate (CAGR) of 4.03% from 2021 to 2030 to reach USD1508.56 million by 2030. Is positron emission tomography still used? The positron emission tomography is still being used, but many end-users are shifting to newer technology like PET-CT and PET-MRI. Is positron emission tomography expensive? Positron emission tomography is expensive, with the cost of one use being around $900 to $1400. What is the most estimated value of the global market? The global market’s estimated value was USD 1016.20 million in 2020. Which region held the largest share in the market? North America is held the largest share in the market, accounting for 42.2% in 2016. Which are the key factors driving the growth of the market? The key drivers for the growth of the market are increasing cancer cases and the expanded applications of PET. How big is the positron emission tomography market? The global positron emission tomography market size was $1057.15 Mn in 2021 and is predicted to reach $1508.56 Mn by 2030, with a CAGR of 4.03%. Sources https://www.mayoclinic.org/tests-procedures/pet-scan/about/pac-20385078 https://www.who.int/news-room/fact-sheets/detail/cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022767/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276948/ https://www.cms.gov/files/document/whitecomment07152022pdf.pdf 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Positron Emission Tomography Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 By Product Type Business Analysis 4.3.1 Global Market, By Product Type, 2021-2030 (USD Million) 4.4 By Application Business Analysis 4.4.1 Global Market, By Application, 2021-2030 (USD Million) 4.5 By Detector Type 4.5.1 Global Market, By Detector Type, 2021-2030 (USD Million) 4.6 By End User 4.6.1 Global Market, By End User, 2021-2030 (USD Million) 4.7 By Region 4.7.1 Global Market, By Region, 2021-2030 (USD Million) 4.8 Value Chain Analysis 4.9 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 5.0 Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 5.1 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Procedure Analysis 5.11.1. Trends in Procedure (2014-2020) 5.11.2. Trends in Procedure (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Brain Monitoring Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2020-2030) 7.3. Full Ring PET Scanner 7.3.1. Full Ring PET Scanner market, 2021-2030 (USD Million) 7.4. Partial Ring PET Scanner 7.4.1. Partial Ring PET Scanner market, 2021-2030 (USD Million) 8. Global Market: By Application Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2020-2030) 8.3. Oncology 8.3.1. Oncology market, 2021-2030 (USD Million) 8.4. Cardiology 8.4.1. Cardiology market, 2021-2030 (USD Million) 8.5. Neurology 8.5.1. Neurology market, 2021-2030 (USD Million) 8.6. Others 8.5.1. Others market, 2021-2030 (USD Million) 9. Global Market: By Detector Type Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2020-2030) 9.3. Bismuth Germanium Oxide (BGO) 9.3.1. Bismuth Germanium Oxide (BGO) market, 2021-2030 (USD Million) 9.4. Lutetium Oxyorthosilicate (LSO) 9.4.1. Lutetium Oxyorthosilicate (LSO), 2021-2030 (USD Million) 9.5. Gadolinium Oxyorthosilicate (GSO) 9.5.1. Gadolinium Oxyorthosilicate (GSO) market, 2021-2030 (USD Million) 9.6. Lutetium Fine Silicate (LFS) 9.6.1. Lutetium Fine Silicate (LFS) market, 2021-2030 (USD Million) 9.6. Lutetium Yttrium Orthosilicate (LYSO) 9.6.1. Lutetium Yttrium Orthosilicate (LYSO) market, 2021-2030 (USD Million) 10. Global Market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2020-2030) 10.3. Hospitals 10.3.1. Hospitals market, 2021-2030 (USD Million) 10.4. Diagnostic Centres 10.4.1. Diagnostic Centres market, 2021-2030 (USD Million) 10.5. PET Centres 10.5.1. PET Centres market, 2021-2030 (USD Million) 10.4. Research Institutes 10.4.1. Research Institutes market, 2021-2030 (USD Million) 11. Global Market: Regional Outlook 11.1 North America 11.1.1. North America Market, By Product Type, 2021-2030 (USD Million) 11.1.2. North America Market, By Application, 2021-2030 (USD Million) 11.1.3. North America Market, By Detector Type, 2021-2030 (USD Million) 11.1.4. North America Market, By End-User, 2021-2030 (USD Million) 11.1.5. North America Market, By Region, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. Market, By Product Type, 2021-2030 (USD Million) 11.1.4.1.2. U.S. Market, By Application, 2021-2030 (USD Million) 11.1.4.1.3. U.S. Market, By Detector Type, 2021-2030 (USD Million) 11.1.4.1.4 U.S. Market, By End-User, 2021-2030 (USD Million) 11.1.4.1.5. U.S. Market, By Region, 2021-2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada Market, By Product Type, 2021-2030 (USD Million) 11.1.4.2.2. Canada Market, By Application, 2021-2030 (USD Million) 11.1.4.2.3. Canada Market, By Detector Type, 2021-2030 (USD Million) 11.1.4.2.4 Canada Market, By End-User, 2021-2030 (USD Million) 11.1.4.2.5. Canada Market, By Region, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe Market, By Product Type, 2021-2030 (USD Million) 11.2.2. Europe Market, By Application, 2021-2030 (USD Million) 11.2.3. Europe Market, By Detector Type, 2021-2030 (USD Million) 11.2.4. Europe Market, By End-User, 2021-2030 (USD Million) 11.2.5 Europe Market, By End-User, 2021-2030 (USD Million) 11.2.6 Europe Market, By Region, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. Market, By Product Type, 2021-2030 (USD Million) 11.2.4.1.2. U.K. Market, By Application, 2021-2030 (USD Million) 11.2.4.1.3. U.K. Market, By Detector Type, 2021-2030 (USD Million) 11.2.4.1.4 U.K Market, By End-User, 2021-2030 (USD Million) 11.2.5.1.5 U.K Market, By Region, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany Market, By Product Type, 2021-2030 (USD Million) 11.2.4.2.2. Germany Market, By Application, 2021-2030 (USD Million) 11.2.4.2.3. Germany Market, By Detector Type, 2021-2030 (USD Million) 11.2.4.2.4 Germany Market, By End-User, 2021-2030 (USD Million) 11.2.4.2.5 Germany Market, By Region, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France Market, By Product Type, 2021-2030 (USD Million) 11.2.4.3.2. France Market, By Application, 2021-2030 (USD Million) 11.2.4.3.3. France Market, By Detector Type, 2021-2030 (USD Million) 11.2.4.3.4 France Market, By End-User, 2021-2030 (USD Million) 11.2.4.3.5 France Market, By Region, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe Market, By Product Type, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe Market, By Application, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe Market, By Detector Type, 2021-2030 (USD Million) 11.2.4.4.4 Rest of Europe Market, By End-User, 2021-2030 (USD Million) 11.2.4.4.5 Rest of Europe Market, By Region, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific Market, By Product Type, 2021-2030 (USD Million) 11.3.2. Asia Pacific Market, By Application, 2021-2030 (USD Million) 11.3.3. Asia Pacific Market, By Detector Type, 2021-2030 (USD Million) 11.3.4. Asia Pacific Market, By End-User, 2021-2030 (USD Million) 11.3.5 Asia Pacific Market, By End-User, 2021-2030 (USD Million) 11.3.6 Asia Pacific Market, By Region, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China Market, By Product Type, 2021-2030 (USD Million) 11.3.4.1.2. China Market, By Application, 2021-2030 (USD Million) 11.3.4.1.3. China Market, By Detector Type, 2021-2030 (USD Million) 11.3.4.1.4 China Market, By End-User, 2021-2030 (USD Million) 11.3.4.1.5 China Market, By Region, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India Market, By Product Type, 2021-2030 (USD Million) 11.3.4.2.2. India Market, By Application, 2021-2030 (USD Million) 11.3.4.2.3. India Market, By Detector Type, 2021-2030 (USD Million) 11.3.4.2.4 India Market, By End-User, 2021-2030 (USD Million) 11.3.4.2.5 India Market, By Region, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan Market, By Product Type, 2021-2030 (USD Million) 11.3.4.3.2. Japan Market, By Application, 2021-2030 (USD Million) 11.3.4.3.3. Japan Market, By Detector Type, 2021-2030 (USD Million) 11.3.4.3.4 Japan Market, By End-User, 2021-2030 (USD Million) 11.3.4.3.5 Japan Market, By Region, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea Market, By Product Type, 2021-2030 (USD Million) 11.3.4.4.2. South Korea Market, By Application, 2021-2030 (USD Million) 11.3.4.4.3. South Korea Market, By Detector Type, 2021-2030 (USD Million) 11.3.4.4.4 South Korea Market, By End-User, 2021-2030 (USD Million) 11.3.4.4.5 South Korea Market, By Region, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC Market, By Product Type, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC Market, By Application, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC Market, By Detector Type, 2021-2030 (USD Million) 11.3.4.5.4 Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million) 11.3.4.5.5 Rest of ASIA PACIFIC Market, By Region, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America Market, By Product Type, 2021-2030 (USD Million) 11.4.2. Latin America Market, By Application, 2021-2030 (USD Million) 11.4.3. Latin America Market, By Detector Type, 2021-2030 (USD Million) 11.4.4 Latin America Market, By End-User, 2021-2030 (USD Million) 11.4.5 Latin America Market, By Region, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil Market, By Product Type, 2021-2030 (USD Million) 11.4.4.1.2. Brazil Market, By Application, 2021-2030 (USD Million) 11.4.4.1.3. Brazil Market, By Detector Type, 2021-2030 (USD Million) 11.4.4.1.4 Brazil America Market, By End-User, 2021-2030 (USD Million) 11.4.4.1.5 Brazil America Market, By Region, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico Market, By Product Type, 2021-2030 (USD Million) 11.4.4.2.2. Mexico Market, By Application, 2021-2030 (USD Million) 11.4.4.2.3. Mexico Market, By Detector Type, 2021-2030 (USD Million) 11.4.4.2.4 Mexico Market, By End-User, 2021-2030 (USD Million) 11.4.4.2.5 Mexico Market, By Region, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America Market, By Product Type, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America Market, By Application, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America Market, By Detector Type, 2021-2030 (USD Million) 11.4.4.3.4 Rest of the Latin America Market, By End-User, 2021-2030 (USD Million) 11.4.4.3.5 Rest of the Latin America Market, By Region, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA Market, By Product Type, 2021-2030 (USD Million) 11.5.2. MEA Market, By Application, 2021-2030 (USD Million) 11.5.3. MEA Market, By Detector Type, 2021-2030 (USD Million) 11.5.4. MEA Market, by Region, 2021-2030 (USD Million) 11.5.5 MEA Market, By End-User, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 Agfa Healthcare 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Product Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Gamma Medica Inc. 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. GE Healthcare 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.3. Neusoft Medical Systems 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Oncovision 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. Koninklijke Philips N.V. 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Positron Corporation 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. Siemens AG 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Segami Corporation 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Spectrum Dynamics Ltd. 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. Naviscan, Inc. 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Product Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. MedX Holdings Inc. 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Product Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. Modus Medical Devices Inc. 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Product Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. Radiology Oncology Systems, Inc. 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.13. Yangzhou Kindsway Biotech Co. Ltd. 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.13. Toshiba Corporation 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.13. Hitachi, Ltd. 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development List of Tables (75 Tables) TABLE 1. Market, By Product, 2020-2030 (USD Million) TABLE 2. Market FOR Full Ring PET Scanner, BY REGION, 2020-2030 (USD Million) TABLE 3. Market FOR Partial Ring PET Scanner, BY REGION, 2020-2030 (USD Million) TABLE 4. Market, By Application, 2020-2030 (USD Million) TABLE 5. Market FOR Oncology, BY REGION, 2020-2030 (USD Million) TABLE 6. Market FOR Cardiology, BY REGION, 2020-2030 (USD Million) TABLE 7. Market FOR Neurology, BY REGION, 2020-2030 (USD Million) TABLE . Market FOR Others, BY REGION, 2020-2030 (USD Million) TABLE 8. Market, BY DETECTOR TYPE, 2020-2030 (USD Million) TABLE 9. Market FOR Bismuth Germanium Oxide (BGO), BY REGION, 2020-2030 (USD Million) TABLE 10. Market FOR Lutetium Oxyorthosilicate (LSO) BY REGION, 2020-2030 (USD Million) TABLE 10. Market FOR Gadolinium Oxyorthosilicate (GSO) BY REGION, 2020-2030 (USD Million) TABLE 11. Market FOR Lutetium Fine Silicate (LFS) BY REGION, 2020-2030 (USD Million) TABLE 12. Market FOR Lutetium Yttrium Orthosilicate (LYSO) BY REGION, 2020-2030 (USD Million) TABLE 11. Market, By End-User, 2020-2030 (USD Million) TABLE 12. Market FOR Hospitals,BY REGION, 2020-2030 (USD Million) TABLE 13. Market FOR Diagnostic Centres, BY REGION, 2020-2030 (USD Million) TABLE 14. Market FOR PET Centres, BY REGION, 2020-2030 (USD Million) TABLE 15. Market FOR Research Institutes, BY REGION, 2020-2030 (USD Million) TABLE 21. Market, BY REGION, 2020-2030 (USD Million) TABLE 22. NORTH AMERICA Market, BY END-USER, 2020-2030 (USD Million) TABLE 23. NORTH AMERICA Market, By Product, 2020-2030 (USD Million) TABLE 24. NORTH AMERICA Market, By End-User, 2020-2030 (USD Million) TABLE 25. NORTH AMERICA Market, BY DETECTOR TYPE, 2020-2030 (USD Million) TABLE 26. EUROPE Market, BY END-USER, 2020-2030 (USD Million) TABLE 27. EUROPE Market, By Product, 2020-2030 (USD Million) TABLE 28. EUROPE Market, By End-User, 2020-2030 (USD Million) TABLE 29. EUROPE Market, BY DETECTOR TYPE, 2020-2030 (USD Million) TABLE 30. ASIA-PACIFIC Market, BY END-USER, 2020-2030 (USD Million) TABLE 31. ASIA-PACIFIC Market, By Product, 2020-2030 (USD Million) TABLE 32. ASIA-PACIFIC Market, By End-User, 2020-2030 (USD Million) TABLE 33. ASIA-PACIFIC Market, BY DETECTOR TYPE, 2020-2030 (USD Million) TABLE 34. LAMEA Market, BY END-USER, 2020-2030 (USD Million) TABLE 35. LAMEA Market, By Product, 2020-2030 (USD Million) TABLE 36. LAMEA Market, By Application, 2020-2030 (USD Million) TABLE 37. LAMEA Market, BY DETECTOR TYPE, 2020-2030 (USD Million) TABLE 38. Corporation: COMPANY SNAPSHOT TABLE 39. Corporation: OPERATING SEGMENTS TABLE 40. Agfa Healthcare, Inc: COMPANY SNAPSHOT TABLE 41. Agfa Healthcare, Inc: OPERATING SEGMENTS TABLE 42. Gamma Medica Inc.: COMPANY SNAPSHOT TABLE 43. Gamma Medica Inc.: OPERATING SEGMENTS TABLE 44. GE Healthcare: COMPANY SNAPSHOT TABLE 45. GE Healthcare: OPERATING SEGMENTS TABLE 46. Neusoft Medical Systems, Inc: COMPANY SNAPSHOT TABLE 47. Neusoft Medical Systems, Inc: OPERATING SEGMENTS TABLE 48. Oncovision, Inc: COMPANY SNAPSHOT TABLE 49. Oncovision, Inc: OPERATING SEGMENTS TABLE 50. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 51. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 52. Positron Corporation COMPANY SNAPSHOT TABLE 53. Positron Corporation OPERATING SEGMENTS TABLE 54. Siemens AG: COMPANY SNAPSHOT TABLE 55. Siemens AG: OPERATING SEGMENTS TABLE 56. Segami Corporation: COMPANY SNAPSHOT TABLE 57. Segami Corporation: OPERATING SEGMENTS TABLE 58. Spectrum Dynamics Ltd.: COMPANY SNAPSHOT TABLE 59. Spectrum Dynamics Ltd.: OPERATING SEGMENTS TABLE 60. Naviscan, Inc.: COMPANY SNAPSHOT TABLE 61. Naviscan, Inc.: OPERATING SEGMENTS TABLE 62. MedX Holdings Inc.: COMPANY SNAPSHOT TABLE 63. MedX Holdings Inc.: OPERATING SEGMENTS TABLE 64. Modus Medical Devices Inc.: COMPANY SNAPSHOT TABLE 65. Modus Medical Devices Inc.: OPERATING SEGMENTS TABLE 66. Radiology Oncology Systems, Inc.: COMPANY SNAPSHOT TABLE 67. Radiology Oncology Systems, Inc.: OPERATING SEGMENTS TABLE 68. Yangzhou Kindsway Biotech Co. Ltd.: COMPANY SNAPSHOT TABLE 69. Yangzhou Kindsway Biotech Co. Ltd.: OPERATING SEGMENTS TABLE 70. Toshiba Corporation: COMPANY SNAPSHOT TABLE 71. Toshiba Corporation: OPERATING SEGMENTS TABLE 72. Integra Lifesciences: COMPANY SNAPSHOT TABLE 73. Hitachi, Ltd.: OPERATING SEGMENTS TABLE 74. Hitachi, Ltd.: COMPANY SNAPSHOT List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 19 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Brain Monitoring, By End-User, 2016–2020 (USD Thousand) Figure 9 Export Data for Brain Monitoring, By End-User, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Detector Type, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 full-ring PET to Witness Higher CAGR in the Market for Product Segment during Forecast Period. Figure 17 Oncology to Witness Higher CAGR in the Market in By application Segment during Forecast Period. Figure 18 Lutetium Oxyorthosilicate (LSO) detector to Witness Higher CAGR in the Market for Detector Type Segment during Forecast Period. Figure 19 Hospital to Witness Higher CAGR in the Market for end-user during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview